22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › Innovent Biologics, Inc. › 2024-2025

Innovent Biologics, Inc. 2024-2025 Proxy Voting Records

At Innovent Biologics, Inc.'s shareholder meeting held June 25, 2025, in the 2024-2025 proxy season, 57 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,332 separate fund positions. Their filings are grouped here into 30 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — Accept Financial Statements and Statutory Reports — the reporting funds cast 100% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings. Page generated November 8, 2026.

  • 30Reported items
  • 57Asset managers
  • 1,332Fund votes
  • June 25, 2025Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from Innovent Biologics, Inc. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore Innovent Biologics, Inc. in the interactive database Compare manager voting policies

How asset managers voted at the Innovent Biologics, Inc. 2024-2025 meeting

Each item below shows how the 57 asset managers that disclosed a Innovent Biologics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Innovent Biologics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Charles Leland Cooney as Director

No official resultsDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: votes by 35 asset managers

The 35 asset managers below reported 115,088,262 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 115,088,262
Largest asset managers voting on “Elect Charles Leland Cooney as Director” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard44,176,5860 00For
Capital Group21,637,8730 00For
EUPAC FUND20,237,5000 00For
Fidelity14,327,7460 00For
American Century3,789,5000 00For
TIAA2,725,8100 00For
State Street2,123,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,495,0000 00For
EMERGING MARKETS EQUITIES FUND INC783,4000 00For
WisdomTree668,2000 00For
Dimensional463,5000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
Northern Trust278,0000 00For
Lazard256,5000 00For
China Fund, Inc.248,5000 00For
Empower232,0000 00For
Lincoln Financial157,5000 00For
Eaton Vance134,0000 00For
Datum One Series Trust116,8360 00For
Polar Capital Holdings Plc116,8360 00For
AIG/SunAmerica113,5000 00For
Franklin Templeton109,0000 00For
AMERICAN BEACON FUNDS92,0170 00For
Voya68,0000 00For
HC CAPITAL TRUST67,0000 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

2. Elect De-Chao Michael Yu as Director

No official resultsDIRECTOR ELECTIONS

99.5% of fund votes cast · no official result

FOR
Details: votes by 35 asset managers

The 35 asset managers below reported 114,578,762 for, 509,500 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 114,578,762AGAINST: 509,500
Largest asset managers voting on “Elect De-Chao Michael Yu as Director” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard44,176,5860 00For
Capital Group21,637,8730 00For
EUPAC FUND20,237,5000 00For
Fidelity14,327,7460 00For
American Century3,789,5000 00For
TIAA2,725,8100 00For
State Street2,123,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,495,0000 00For
EMERGING MARKETS EQUITIES FUND INC783,4000 00For
WisdomTree668,2000 00For
Dimensional463,5000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
Northern Trust0278,000 00Against
Lazard256,5000 00For
China Fund, Inc.248,5000 00For
Empower232,0000 00For
Lincoln Financial157,5000 00For
Eaton Vance0134,000 00Against
Datum One Series Trust116,8360 00For
Polar Capital Holdings Plc116,8360 00For
AIG/SunAmerica113,5000 00For
Franklin Templeton109,0000 00For
AMERICAN BEACON FUNDS92,0170 00For
Voya068,000 00Against
HC CAPITAL TRUST67,0000 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

3. Elect Gary Zieziula as Director

No official resultsDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: votes by 35 asset managers

The 35 asset managers below reported 115,088,262 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 115,088,262
Largest asset managers voting on “Elect Gary Zieziula as Director” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard44,176,5860 00For
Capital Group21,637,8730 00For
EUPAC FUND20,237,5000 00For
Fidelity14,327,7460 00For
American Century3,789,5000 00For
TIAA2,725,8100 00For
State Street2,123,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,495,0000 00For
EMERGING MARKETS EQUITIES FUND INC783,4000 00For
WisdomTree668,2000 00For
Dimensional463,5000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
Northern Trust278,0000 00For
Lazard256,5000 00For
China Fund, Inc.248,5000 00For
Empower232,0000 00For
Lincoln Financial157,5000 00For
Eaton Vance134,0000 00For
Datum One Series Trust116,8360 00For
Polar Capital Holdings Plc116,8360 00For
AIG/SunAmerica113,5000 00For
Franklin Templeton109,0000 00For
AMERICAN BEACON FUNDS92,0170 00For
Voya68,0000 00For
HC CAPITAL TRUST67,0000 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

4. TO RE-ELECT DR. CHARLES LELAND COONEY AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR OF THE COMPANY

No official resultsDIRECTOR ELECTIONS

98% of fund votes cast · no official result

FOR
Details: votes by 15 asset managers

The 15 asset managers below reported 26,685,855 for, 429,500 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 26,685,855AGAINST: 429,500
Largest asset managers voting on “TO RE-ELECT DR. CHARLES LELAND COONEY AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR OF THE COMPANY” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock25,104,5000 00For
Krane Shares Trust0429,500 00Against
JPMorgan390,0000 00For
Calamos245,0000 00For
John Hancock241,5210 00For
Roundhill ETF Trust185,5000 00For
MASTER INVESTMENT PORTFOLIO170,0000 00For
Jackson National119,0000 00For
Touchstone ETF Trust73,8710 00For
AMG Funds I60,0000 00For
PFM Multi-Manager Series Trust60,0000 00For
Amplify ETF Trust23,0000 00For
Forethought Variable Insurance Trust7,0000 00For
WILSHIRE MUTUAL FUNDS INC3,5000 00For
GPS Funds I2,9630 00For

5. TO RE-ELECT DR. DE-CHAO MICHAEL YU AS AN EXECUTIVE DIRECTOR OF THE COMPANY

No official resultsDIRECTOR ELECTIONS

98% of fund votes cast · no official result

FOR
Details: votes by 15 asset managers

The 15 asset managers below reported 26,662,855 for, 452,500 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 26,662,855AGAINST: 452,500
Largest asset managers voting on “TO RE-ELECT DR. DE-CHAO MICHAEL YU AS AN EXECUTIVE DIRECTOR OF THE COMPANY” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock25,104,5000 00For
Krane Shares Trust0429,500 00Against
JPMorgan390,0000 00For
Calamos245,0000 00For
John Hancock241,5210 00For
Roundhill ETF Trust185,5000 00For
MASTER INVESTMENT PORTFOLIO170,0000 00For
Jackson National119,0000 00For
Touchstone ETF Trust73,8710 00For
AMG Funds I60,0000 00For
PFM Multi-Manager Series Trust60,0000 00For
Amplify ETF Trust023,000 00Against
Forethought Variable Insurance Trust7,0000 00For
WILSHIRE MUTUAL FUNDS INC3,5000 00For
GPS Funds I2,9630 00For

6. TO RE-ELECT MR. GARY ZIEZIULA AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR OF THE COMPANY

No official resultsDIRECTOR ELECTIONS

99.9% of fund votes cast · no official result

FOR
Details: votes by 15 asset managers

The 15 asset managers below reported 27,092,355 for, 23,000 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 27,092,355AGAINST: 23,000
Largest asset managers voting on “TO RE-ELECT MR. GARY ZIEZIULA AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR OF THE COMPANY” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock25,104,5000 00For
Krane Shares Trust429,5000 00For
JPMorgan390,0000 00For
Calamos245,0000 00For
John Hancock241,5210 00For
Roundhill ETF Trust185,5000 00For
MASTER INVESTMENT PORTFOLIO170,0000 00For
Jackson National119,0000 00For
Touchstone ETF Trust73,8710 00For
AMG Funds I60,0000 00For
PFM Multi-Manager Series Trust60,0000 00For
Amplify ETF Trust023,000 00Against
Forethought Variable Insurance Trust7,0000 00For
WILSHIRE MUTUAL FUNDS INC3,5000 00For
GPS Funds I2,9630 00For

7. Elect Charles L. Cooney

No official resultsDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: votes by 6 asset managers

The 6 asset managers below reported 6,005,649 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,005,649
Largest asset managers voting on “Elect Charles L. Cooney” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Hartford3,321,0000 00For
Charles Schwab1,751,0470 00For
Fidelity807,1020 00For
Russell Investments102,5000 00For
Prudential/PGIM17,5000 00For
Neuberger Berman6,5000 00For

8. Elect Gary Zieziula

No official resultsDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: votes by 6 asset managers

The 6 asset managers below reported 6,005,649 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,005,649
Largest asset managers voting on “Elect Gary Zieziula” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Hartford3,321,0000 00For
Charles Schwab1,751,0470 00For
Fidelity807,1020 00For
Russell Investments102,5000 00For
Prudential/PGIM17,5000 00For
Neuberger Berman6,5000 00For

9. Elect Michael YU De-Chao

No official resultsDIRECTOR ELECTIONS

100% of fund votes cast · no official result

FOR
Details: votes by 6 asset managers

The 6 asset managers below reported 6,005,649 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,005,649
Largest asset managers voting on “Elect Michael YU De-Chao” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Hartford3,321,0000 00For
Charles Schwab1,751,0470 00For
Fidelity807,1020 00For
Russell Investments102,5000 00For
Prudential/PGIM17,5000 00For
Neuberger Berman6,5000 00For

10. Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights

No official resultsCAPITAL STRUCTURE

77% of fund votes cast · no official result

FORAGAINST
Details: votes by 35 asset managers

The 35 asset managers below reported 88,127,359 for, 26,960,903 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 88,127,359AGAINST: 26,960,903
Largest asset managers voting on “Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard44,176,5860 00For
Capital Group21,637,8730 00For
EUPAC FUND20,237,5000 00For
Fidelity1,292,00013,035,746 00Mixed
American Century03,789,500 00Against
TIAA02,725,810 00Against
State Street02,123,000 00Against
MATTHEWS INTERNATIONAL FUNDS01,495,000 00Against
EMERGING MARKETS EQUITIES FUND INC783,4000 00For
WisdomTree0668,200 00Against
Dimensional0463,500 00Against
TEMPLETON DRAGON FUND INC0452,519 00Against
Northern Trust0278,000 00Against
Lazard0256,500 00Against
China Fund, Inc.0248,500 00Against
Empower0232,000 00Against
Lincoln Financial0157,500 00Against
Eaton Vance0134,000 00Against
Datum One Series Trust0116,836 00Against
Polar Capital Holdings Plc0116,836 00Against
AIG/SunAmerica0113,500 00Against
Franklin Templeton0109,000 00Against
AMERICAN BEACON FUNDS092,017 00Against
Voya068,000 00Against
HC CAPITAL TRUST067,000 00Against

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

11. Authorize Reissuance of Repurchased Shares

No official resultsCAPITAL STRUCTURE

38% of fund votes cast · no official result

FORAGAINST
Details: votes by 35 asset managers

The 35 asset managers below reported 44,176,586 for, 70,911,676 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 44,176,586AGAINST: 70,911,676
Largest asset managers voting on “Authorize Reissuance of Repurchased Shares” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard44,176,5860 00For
Capital Group021,637,873 00Against
EUPAC FUND020,237,500 00Against
Fidelity014,327,746 00Against
American Century03,789,500 00Against
TIAA02,725,810 00Against
State Street02,123,000 00Against
MATTHEWS INTERNATIONAL FUNDS01,495,000 00Against
EMERGING MARKETS EQUITIES FUND INC0783,400 00Against
WisdomTree0668,200 00Against
Dimensional0463,500 00Against
TEMPLETON DRAGON FUND INC0452,519 00Against
Northern Trust0278,000 00Against
Lazard0256,500 00Against
China Fund, Inc.0248,500 00Against
Empower0232,000 00Against
Lincoln Financial0157,500 00Against
Eaton Vance0134,000 00Against
Datum One Series Trust0116,836 00Against
Polar Capital Holdings Plc0116,836 00Against
AIG/SunAmerica0113,500 00Against
Franklin Templeton0109,000 00Against
AMERICAN BEACON FUNDS092,017 00Against
Voya068,000 00Against
HC CAPITAL TRUST067,000 00Against

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

12. Authorize Repurchase of Issued Share Capital

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: votes by 35 asset managers

The 35 asset managers below reported 115,088,262 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 115,088,262
Largest asset managers voting on “Authorize Repurchase of Issued Share Capital” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard44,176,5860 00For
Capital Group21,637,8730 00For
EUPAC FUND20,237,5000 00For
Fidelity14,327,7460 00For
American Century3,789,5000 00For
TIAA2,725,8100 00For
State Street2,123,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,495,0000 00For
EMERGING MARKETS EQUITIES FUND INC783,4000 00For
WisdomTree668,2000 00For
Dimensional463,5000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
Northern Trust278,0000 00For
Lazard256,5000 00For
China Fund, Inc.248,5000 00For
Empower232,0000 00For
Lincoln Financial157,5000 00For
Eaton Vance134,0000 00For
Datum One Series Trust116,8360 00For
Polar Capital Holdings Plc116,8360 00For
AIG/SunAmerica113,5000 00For
Franklin Templeton109,0000 00For
AMERICAN BEACON FUNDS92,0170 00For
Voya68,0000 00For
HC CAPITAL TRUST67,0000 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

13. To extend the general mandate granted to the directors to issue shares of the company by adding thereto the total…

No official resultsCAPITAL STRUCTURE

1.0% of fund votes cast · no official result

AGAINST
Details: description as filed, votes by 15 asset managers

Description as filed by funds: TO EXTEND THE GENERAL MANDATE GRANTED TO THE DIRECTORS TO ISSUE SHARES OF THE COMPANY BY ADDING THERETO THE TOTAL NUMBER OF THE SHARES TO BE BOUGHT BACK BY THE COMPANY (EXCLUDING ANY SHARES THAT ARE HELD AS TREASURY SHARES, IF ANY)

The 15 asset managers below reported 268,000 for, 26,847,355 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 268,000AGAINST: 26,847,355
Largest asset managers voting on “TO EXTEND THE GENERAL MANDATE GRANTED TO THE DIRECTORS TO ISSUE SHARES OF THE COMPANY BY ADDING THERETO THE TO” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock025,104,500 00Against
Krane Shares Trust0429,500 00Against
JPMorgan0390,000 00Against
Calamos245,0000 00For
John Hancock0241,521 00Against
Roundhill ETF Trust0185,500 00Against
MASTER INVESTMENT PORTFOLIO0170,000 00Against
Jackson National0119,000 00Against
Touchstone ETF Trust073,871 00Against
AMG Funds I060,000 00Against
PFM Multi-Manager Series Trust060,000 00Against
Amplify ETF Trust23,0000 00For
Forethought Variable Insurance Trust07,000 00Against
WILSHIRE MUTUAL FUNDS INC03,500 00Against
GPS Funds I02,963 00Against

14. To Grant a general mandate to the directors to allot, issue and deal with additional shares of the company (excluding…

No official resultsCAPITAL STRUCTURE

1.0% of fund votes cast · no official result

AGAINST
Details: description as filed, votes by 15 asset managers

Description as filed by funds: TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY (EXCLUDING ANY SHARES THAT ARE HELD AS TREASURY SHARES, IF ANY)

The 15 asset managers below reported 268,000 for, 26,847,355 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 268,000AGAINST: 26,847,355
Largest asset managers voting on “TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY (EX” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock025,104,500 00Against
Krane Shares Trust0429,500 00Against
JPMorgan0390,000 00Against
Calamos245,0000 00For
John Hancock0241,521 00Against
Roundhill ETF Trust0185,500 00Against
MASTER INVESTMENT PORTFOLIO0170,000 00Against
Jackson National0119,000 00Against
Touchstone ETF Trust073,871 00Against
AMG Funds I060,000 00Against
PFM Multi-Manager Series Trust060,000 00Against
Amplify ETF Trust23,0000 00For
Forethought Variable Insurance Trust07,000 00Against
WILSHIRE MUTUAL FUNDS INC03,500 00Against
GPS Funds I02,963 00Against

15. To Grant a general mandate to the directors to BUY back shares of the company (excluding any shares that are held as…

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 15 asset managers

Description as filed by funds: TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO BUY BACK SHARES OF THE COMPANY (EXCLUDING ANY SHARES THAT ARE HELD AS TREASURY SHARES, IF ANY)

The 15 asset managers below reported 27,115,355 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 27,115,355
Largest asset managers voting on “TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO BUY BACK SHARES OF THE COMPANY (EXCLUDING ANY SHARES THAT ARE H” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock25,104,5000 00For
Krane Shares Trust429,5000 00For
JPMorgan390,0000 00For
Calamos245,0000 00For
John Hancock241,5210 00For
Roundhill ETF Trust185,5000 00For
MASTER INVESTMENT PORTFOLIO170,0000 00For
Jackson National119,0000 00For
Touchstone ETF Trust73,8710 00For
AMG Funds I60,0000 00For
PFM Multi-Manager Series Trust60,0000 00For
Amplify ETF Trust23,0000 00For
Forethought Variable Insurance Trust7,0000 00For
WILSHIRE MUTUAL FUNDS INC3,5000 00For
GPS Funds I2,9630 00For

16. Authority to Issue Repurchased Shares

No official resultsCAPITAL STRUCTURE

0.3% of fund votes cast · no official result

AGAINST
Details: votes by 6 asset managers

The 6 asset managers below reported 17,500 for, 5,988,149 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 17,500AGAINST: 5,988,149
Largest asset managers voting on “Authority to Issue Repurchased Shares” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Hartford03,321,000 00Against
Charles Schwab01,751,047 00Against
Fidelity0807,102 00Against
Russell Investments0102,500 00Against
Prudential/PGIM17,5000 00For
Neuberger Berman06,500 00Against

17. Authority to Issue Shares w/o Preemptive Rights

No official resultsCAPITAL STRUCTURE

0% of fund votes cast · no official result

AGAINST
Details: votes by 6 asset managers

The 6 asset managers below reported 6,005,649 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

AGAINST: 6,005,649
Largest asset managers voting on “Authority to Issue Shares w/o Preemptive Rights” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Hartford03,321,000 00Against
Charles Schwab01,751,047 00Against
Fidelity0807,102 00Against
Russell Investments0102,500 00Against
Prudential/PGIM017,500 00Against
Neuberger Berman06,500 00Against

18. Authority to Repurchase Shares

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: votes by 6 asset managers

The 6 asset managers below reported 6,005,649 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,005,649
Largest asset managers voting on “Authority to Repurchase Shares” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Hartford3,321,0000 00For
Charles Schwab1,751,0470 00For
Fidelity807,1020 00For
Russell Investments102,5000 00For
Prudential/PGIM17,5000 00For
Neuberger Berman6,5000 00For

19. Accept Financial Statements and Statutory Reports

No official resultsCORPORATE GOVERNANCE

100% of fund votes cast · no official result

FOR
Details: votes by 35 asset managers

The 35 asset managers below reported 115,088,262 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 115,088,262
Largest asset managers voting on “Accept Financial Statements and Statutory Reports” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard44,176,5860 00For
Capital Group21,637,8730 00For
EUPAC FUND20,237,5000 00For
Fidelity14,327,7460 00For
American Century3,789,5000 00For
TIAA2,725,8100 00For
State Street2,123,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,495,0000 00For
EMERGING MARKETS EQUITIES FUND INC783,4000 00For
WisdomTree668,2000 00For
Dimensional463,5000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
Northern Trust278,0000 00For
Lazard256,5000 00For
China Fund, Inc.248,5000 00For
Empower232,0000 00For
Lincoln Financial157,5000 00For
Eaton Vance134,0000 00For
Datum One Series Trust116,8360 00For
Polar Capital Holdings Plc116,8360 00For
AIG/SunAmerica113,5000 00For
Franklin Templeton109,0000 00For
AMERICAN BEACON FUNDS92,0170 00For
Voya68,0000 00For
HC CAPITAL TRUST67,0000 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

20. Accounts and Reports

No official resultsCORPORATE GOVERNANCE

100% of fund votes cast · no official result

FOR
Details: votes by 6 asset managers

The 6 asset managers below reported 6,005,649 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,005,649
Largest asset managers voting on “Accounts and Reports” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Hartford3,321,0000 00For
Charles Schwab1,751,0470 00For
Fidelity807,1020 00For
Russell Investments102,5000 00For
Prudential/PGIM17,5000 00For
Neuberger Berman6,5000 00For

21. Approve Grant of Restricted Shares to De-Chao Michael Yu

87% of fund votes cast · no official result

FOR
Details: votes by 35 asset managers

The 35 asset managers below reported 100,114,918 for, 14,973,344 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 100,114,918AGAINST: 14,973,344
Largest asset managers voting on “Approve Grant of Restricted Shares to De-Chao Michael Yu” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard44,176,5860 00For
Capital Group21,637,8730 00For
EUPAC FUND20,237,5000 00For
Fidelity8,532,2495,795,497 00Mixed
American Century03,789,500 00Against
TIAA2,725,8100 00For
State Street02,123,000 00Against
MATTHEWS INTERNATIONAL FUNDS1,495,0000 00For
EMERGING MARKETS EQUITIES FUND INC783,4000 00For
WisdomTree0668,200 00Against
Dimensional0463,500 00Against
TEMPLETON DRAGON FUND INC0452,519 00Against
Northern Trust278,0000 00For
Lazard0256,500 00Against
China Fund, Inc.248,5000 00For
Empower0232,000 00Against
Lincoln Financial0157,500 00Against
Eaton Vance0134,000 00Against
Datum One Series Trust0116,836 00Against
Polar Capital Holdings Plc0116,836 00Against
AIG/SunAmerica0113,500 00Against
Franklin Templeton0109,000 00Against
AMERICAN BEACON FUNDS092,017 00Against
Voya068,000 00Against
HC CAPITAL TRUST067,000 00Against

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

22. Authorize Board to Fix Remuneration of Directors

94% of fund votes cast · no official result

FOR
Details: votes by 35 asset managers

The 35 asset managers below reported 107,838,074 for, 7,250,188 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 107,838,074AGAINST: 7,250,188
Largest asset managers voting on “Authorize Board to Fix Remuneration of Directors” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard44,176,5860 00For
Capital Group21,637,8730 00For
EUPAC FUND20,237,5000 00For
Fidelity7,087,4977,240,249 00Mixed
American Century3,789,5000 00For
TIAA2,725,8100 00For
State Street2,123,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,495,0000 00For
EMERGING MARKETS EQUITIES FUND INC783,4000 00For
WisdomTree668,2000 00For
Dimensional463,5000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
Northern Trust278,0000 00For
Lazard256,5000 00For
China Fund, Inc.248,5000 00For
Empower232,0000 00For
Lincoln Financial157,5000 00For
Eaton Vance134,0000 00For
Datum One Series Trust116,8360 00For
Polar Capital Holdings Plc116,8360 00For
AIG/SunAmerica113,5000 00For
Franklin Templeton109,0000 00For
AMERICAN BEACON FUNDS92,0170 00For
Voya68,0000 00For
HC CAPITAL TRUST67,0000 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

23. To authorise the board of directors (the director(s)) of the company (the board) to fix the remuneration of the…

No official resultsSECTION 14A SAY-ON-PAY VOTES

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 17 asset managers

Description as filed by funds: TO AUTHORISE THE BOARD OF DIRECTORS (THE DIRECTOR(S)) OF THE COMPANY (THE BOARD) TO FIX THE REMUNERATION OF THE DIRECTORS

The 17 asset managers below reported 27,115,355 for, 76,000 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 27,115,355ABSTAIN: 76,000
Largest asset managers voting on “TO AUTHORISE THE BOARD OF DIRECTORS (THE DIRECTOR(S)) OF THE COMPANY (THE BOARD) TO FIX THE REMUNERATION OF TH” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock25,104,5000 00For
Krane Shares Trust429,5000 00For
JPMorgan390,0000 00For
Calamos245,0000 00For
John Hancock241,5210 00For
Roundhill ETF Trust185,5000 00For
MASTER INVESTMENT PORTFOLIO170,0000 00For
Jackson National119,0000 00For
FORMULA GROWTH LTD00 76,0000Abstain
Touchstone ETF Trust73,8710 00For
AMG Funds I60,0000 00For
PFM Multi-Manager Series Trust60,0000 00For
Amplify ETF Trust23,0000 00For
Forethought Variable Insurance Trust7,0000 00For
WILSHIRE MUTUAL FUNDS INC3,5000 00For
GPS Funds I2,9630 00For
Tiger Pacific Capital LP00 00--

24. To approve the Grant of 2,754,000 restricted shares to DR. de-chao michael YU on March 28, 2025 in accordance with the…

No official resultsCAPITAL STRUCTURECOMPENSATION

3% of fund votes cast · no official result

AGAINST
Details: description as filed, votes by 15 asset managers

Description as filed by funds: TO APPROVE THE GRANT OF 2,754,000 RESTRICTED SHARES TO DR. DE-CHAO MICHAEL YU ON MARCH 28, 2025 IN ACCORDANCE WITH THE TERMS OF THE SHARE INCENTIVE SCHEME ADOPTED BY THE COMPANY ON JUNE 21, 2024

The 15 asset managers below reported 834,871 for, 26,280,484 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 834,871AGAINST: 26,280,484
Largest asset managers voting on “TO APPROVE THE GRANT OF 2,754,000 RESTRICTED SHARES TO DR. DE-CHAO MICHAEL YU ON MARCH 28, 2025 IN ACCORDANCE ” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock025,104,500 00Against
Krane Shares Trust429,5000 00For
JPMorgan0390,000 00Against
Calamos245,0000 00For
John Hancock0241,521 00Against
Roundhill ETF Trust0185,500 00Against
MASTER INVESTMENT PORTFOLIO0170,000 00Against
Jackson National0119,000 00Against
Touchstone ETF Trust73,8710 00For
AMG Funds I060,000 00Against
PFM Multi-Manager Series Trust60,0000 00For
Amplify ETF Trust23,0000 00For
Forethought Variable Insurance Trust07,000 00Against
WILSHIRE MUTUAL FUNDS INC3,5000 00For
GPS Funds I02,963 00Against

25. Directors' Fees

100% of fund votes cast · no official result

FOR
Details: votes by 6 asset managers

The 6 asset managers below reported 6,005,649 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,005,649
Largest asset managers voting on “Directors' Fees” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Hartford3,321,0000 00For
Charles Schwab1,751,0470 00For
Fidelity807,1020 00For
Russell Investments102,5000 00For
Prudential/PGIM17,5000 00For
Neuberger Berman6,5000 00For

26. Grant of Restricted Shares to De-Chao Michael Yu

100% of fund votes cast · no official result

FOR
Details: votes by 6 asset managers

The 6 asset managers below reported 6,005,649 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,005,649
Largest asset managers voting on “Grant of Restricted Shares to De-Chao Michael Yu” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Hartford3,321,0000 00For
Charles Schwab1,751,0470 00For
Fidelity807,1020 00For
Russell Investments102,5000 00For
Prudential/PGIM17,5000 00For
Neuberger Berman6,5000 00For

27. Approve Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration

No official resultsAUDIT-RELATED

100% of fund votes cast · no official result

FOR
Details: votes by 35 asset managers

The 35 asset managers below reported 115,088,262 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 115,088,262
Largest asset managers voting on “Approve Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard44,176,5860 00For
Capital Group21,637,8730 00For
EUPAC FUND20,237,5000 00For
Fidelity14,327,7460 00For
American Century3,789,5000 00For
TIAA2,725,8100 00For
State Street2,123,0000 00For
MATTHEWS INTERNATIONAL FUNDS1,495,0000 00For
EMERGING MARKETS EQUITIES FUND INC783,4000 00For
WisdomTree668,2000 00For
Dimensional463,5000 00For
TEMPLETON DRAGON FUND INC452,5190 00For
Northern Trust278,0000 00For
Lazard256,5000 00For
China Fund, Inc.248,5000 00For
Empower232,0000 00For
Lincoln Financial157,5000 00For
Eaton Vance134,0000 00For
Datum One Series Trust116,8360 00For
Polar Capital Holdings Plc116,8360 00For
AIG/SunAmerica113,5000 00For
Franklin Templeton109,0000 00For
AMERICAN BEACON FUNDS92,0170 00For
Voya68,0000 00For
HC CAPITAL TRUST67,0000 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

28. To consider and receive the audited consolidated financial statements of the company and the reports of directors and…

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 15 asset managers

Description as filed by funds: TO CONSIDER AND RECEIVE THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY AND THE REPORTS OF DIRECTORS AND THE AUDITOR OF THE COMPANY FOR THE YEAR ENDED DECEMBER 31, 2024

The 15 asset managers below reported 27,115,355 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 27,115,355
Largest asset managers voting on “TO CONSIDER AND RECEIVE THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY AND THE REPORTS OF DIRECT” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock25,104,5000 00For
Krane Shares Trust429,5000 00For
JPMorgan390,0000 00For
Calamos245,0000 00For
John Hancock241,5210 00For
Roundhill ETF Trust185,5000 00For
MASTER INVESTMENT PORTFOLIO170,0000 00For
Jackson National119,0000 00For
Touchstone ETF Trust73,8710 00For
AMG Funds I60,0000 00For
PFM Multi-Manager Series Trust60,0000 00For
Amplify ETF Trust23,0000 00For
Forethought Variable Insurance Trust7,0000 00For
WILSHIRE MUTUAL FUNDS INC3,5000 00For
GPS Funds I2,9630 00For

29. To re-appoint Deloitte Touche tohmatsu as auditor of the company and authorise the board to fix their remuneration

No official resultsAUDIT-RELATED

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 15 asset managers

Description as filed by funds: TO RE-APPOINT DELOITTE TOUCHE TOHMATSU AS AUDITOR OF THE COMPANY AND AUTHORISE THE BOARD TO FIX THEIR REMUNERATION

The 15 asset managers below reported 27,092,355 for, 23,000 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 27,092,355AGAINST: 23,000
Largest asset managers voting on “TO RE-APPOINT DELOITTE TOUCHE TOHMATSU AS AUDITOR OF THE COMPANY AND AUTHORISE THE BOARD TO FIX THEIR REMUNERA” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock25,104,5000 00For
Krane Shares Trust429,5000 00For
JPMorgan390,0000 00For
Calamos245,0000 00For
John Hancock241,5210 00For
Roundhill ETF Trust185,5000 00For
MASTER INVESTMENT PORTFOLIO170,0000 00For
Jackson National119,0000 00For
Touchstone ETF Trust73,8710 00For
AMG Funds I60,0000 00For
PFM Multi-Manager Series Trust60,0000 00For
Amplify ETF Trust023,000 00Against
Forethought Variable Insurance Trust7,0000 00For
WILSHIRE MUTUAL FUNDS INC3,5000 00For
GPS Funds I2,9630 00For

30. Appointment of Auditor and Authority to Set Fees

No official resultsAUDIT-RELATED

100% of fund votes cast · no official result

FOR
Details: votes by 6 asset managers

The 6 asset managers below reported 6,005,649 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,005,649
Largest asset managers voting on “Appointment of Auditor and Authority to Set Fees” at Innovent Biologics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Hartford3,321,0000 00For
Charles Schwab1,751,0470 00For
Fidelity807,1020 00For
Russell Investments102,5000 00For
Prudential/PGIM17,5000 00For
Neuberger Berman6,5000 00For

Largest Innovent Biologics, Inc. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.

Fund voting reports: top Innovent Biologics, Inc. shareholders by shares voted on “Accept Financial Statements and Statutory Reports”, 2024-2025
#Asset manager Shares voted
1Vanguard 44,176,586
2Capital Group 21,637,873
3EUPAC FUND 20,237,500
4Fidelity 14,327,746
5American Century 3,789,500
6TIAA 2,725,810
7State Street 2,123,000
8MATTHEWS INTERNATIONAL FUNDS 1,495,000
9EMERGING MARKETS EQUITIES FUND INC 783,400
10WisdomTree 668,200
Institutional-manager reports: top Innovent Biologics, Inc. shareholders by shares voted on “Accept Financial Statements and Statutory Reports”, 2024-2025
#Asset manager Shares voted
1Polar Capital Holdings Plc 116,836

Shown as share counts, not percentages: no shares-outstanding figure has been matched to Innovent Biologics, Inc. for the 2024-2025 season, so there is no denominator to divide by.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

Innovent Biologics, Inc. proxy season coverage: 2024-2025 (this page) · 2025-2026.

Cite this page

proxyvotesnow.com, “Innovent Biologics, Inc. 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/innovent-biologics-inc/2025 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.